Stock listing
NASDAQ:CDIO Cardio Diagnostics Holdings Inc. Stock
Home listing (NASDAQ) of Cardio Diagnostics Holdings Inc.
Follow Cardio Diagnostics Holdings Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CDIO
$1.60 USD -0.09 (-5.3%)
Close on Nov 20, 2026
- Day range
- $1.53 – $1.68 USDNov 20, 2026
- Volume
- 32,028 sharesNov 20, 2026
- Market cap
- $4.74M USDAt the close on Nov 20, 2026 · price × 2.96M shares outstanding
- 52-week range
- $0.97 – $7.91 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $51,729 USDMedian day 24,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CDIO · Home | $1.60 USD | -0.09 (-5.3%) | 32,028 | $1.683 | $1.683 | $1.53 | $1.69 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CDIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.60 | -0.09 | -5.3% | $1.683 | $1.683 | $1.53 | 32,028 | |
| $1.69 | -0.02 | -1.2% | $1.76 | $1.76 | $1.668 | 13,733 | |
| $1.71 | -0.08 | -4.5% | $1.80 | $1.83 | $1.655 | 24,454 | |
| $1.79 | -0.10 | -5.3% | $1.95 | $1.96 | $1.76 | 21,651 | |
| $1.89 | +0.02 | +1.1% | $1.93 | $2.09 | $1.89 | 38,704 | |
| $1.87 | -0.05 | -2.6% | $1.97 | $1.99 | $1.80 | 26,179 | |
| $1.92 | +0.06 | +3.2% | $1.88 | $1.96 | $1.87 | 9,506 | |
| $1.86 | +0.04 | +2.2% | $1.81 | $1.90 | $1.81 | 11,645 | |
| $1.82 | +0.169 | +10.2% | $1.725 | $1.83 | $1.725 | 21,512 | |
| $1.651 | -0.024 | -1.4% | $1.70 | $1.71 | $1.60 | 18,807 | |
| $1.675 | +0.03 | +1.8% | $1.69 | $1.745 | $1.585 | 25,092 | |
| $1.645 | +0.045 | +2.8% | $1.60 | $1.693 | $1.60 | 9,094 | |
| $1.60 | -0.07 | -4.2% | $1.60 | $1.67 | $1.60 | 7,738 | |
| $1.67 | 0.00 | 0.0% | $1.74 | $1.74 | $1.66 | 3,226 | |
| $1.67 | -0.08 | -4.6% | $1.705 | $1.75 | $1.67 | 12,035 | |
| $1.75 | +0.05 | +2.9% | $1.728 | $1.78 | $1.70 | 5,714 | |
| $1.70 | 0.00 | 0.0% | $1.69 | $1.75 | $1.69 | 9,163 | |
| $1.70 | -0.02 | -1.2% | $1.72 | $1.73 | $1.68 | 9,057 | |
| $1.72 | +0.03 | +1.8% | $1.77 | $1.77 | $1.69 | 5,974 | |
| $1.69 | -0.015 | -0.9% | $1.795 | $1.795 | $1.69 | 12,000 | |
| $1.705 | -0.065 | -3.7% | $1.80 | $1.80 | $1.69 | 44,000 | |
| $1.77 | +0.05 | +2.9% | $1.805 | $1.84 | $1.71 | 29,300 | |
| $1.72 | +0.08 | +4.9% | $1.64 | $1.78 | $1.64 | 52,200 | |
| $1.64 | -0.05 | -3.0% | $1.70 | $1.727 | $1.55 | 12,500 | |
| $1.69 | -0.07 | -4.0% | $1.78 | $1.84 | $1.687 | 6,800 | |
| $1.76 | +0.09 | +5.4% | $1.67 | $1.84 | $1.67 | 27,300 | |
| $1.67 | -0.08 | -4.6% | $1.77 | $1.779 | $1.67 | 31,900 | |
| $1.75 | -0.03 | -1.7% | $1.86 | $1.86 | $1.75 | 19,800 | |
| $1.78 | -0.09 | -4.8% | $1.90 | $1.91 | $1.655 | 61,600 | |
| $1.87 | +0.01 | +0.5% | $1.90 | $1.95 | $1.87 | 16,400 | |
| $1.86 | -0.10 | -5.1% | $1.99 | $1.99 | $1.85 | 57,300 | |
| $1.96 | -0.04 | -2.0% | $1.995 | $2.03 | $1.95 | 30,200 | |
| $2.00 | -0.06 | -2.9% | $2.02 | $2.07 | $1.98 | 20,900 | |
| $2.06 | +0.10 | +5.1% | $1.98 | $2.23 | $1.98 | 39,100 | |
| $1.96 | +0.04 | +2.1% | $1.97 | $1.97 | $1.86 | 26,100 | |
| $1.92 | +0.02 | +1.1% | $1.88 | $1.95 | $1.878 | 16,800 | |
| $1.90 | +0.03 | +1.6% | $1.87 | $2.018 | $1.85 | 33,500 | |
| $1.87 | -0.024 | -1.3% | $1.91 | $1.92 | $1.85 | 37,800 | |
| $1.894 | -0.056 | -2.9% | $1.939 | $1.95 | $1.88 | 10,300 | |
| $1.95 | +0.04 | +2.1% | $1.90 | $1.97 | $1.89 | 38,900 | |
| $1.91 | -0.01 | -0.5% | $1.93 | $1.971 | $1.89 | 17,600 | |
| $1.92 | 0.00 | 0.0% | $1.98 | $2.03 | $1.87 | 32,600 | |
| $1.92 | 0.00 | 0.0% | $1.94 | $1.96 | $1.912 | 16,000 | |
| $1.92 | -0.10 | -5.0% | $2.07 | $2.07 | $1.91 | 23,700 | |
| $2.02 | -0.01 | -0.5% | $2.04 | $2.163 | $1.92 | 71,600 | |
| $2.03 | +0.03 | +1.5% | $2.00 | $2.066 | $2.00 | 27,800 | |
| $2.00 | 0.00 | 0.0% | $1.99 | $2.06 | $1.92 | 33,000 | |
| $2.00 | -0.07 | -3.4% | $2.15 | $2.16 | $1.92 | 63,300 | |
| $2.07 | +0.04 | +2.0% | $2.03 | $2.14 | $2.025 | 21,700 | |
| $2.03 | +0.05 | +2.5% | $2.05 | $2.09 | $1.98 | 25,200 | |
| $1.98 | -0.09 | -4.3% | $2.02 | $2.14 | $1.98 | 24,100 | |
| $2.07 | +0.11 | +5.6% | $1.98 | $2.09 | $1.95 | 54,700 | |
| $1.96 | +0.10 | +5.4% | $1.88 | $2.10 | $1.85 | 58,000 | |
| $1.86 | +0.03 | +1.6% | $1.85 | $1.86 | $1.82 | 10,300 | |
| $1.83 | -0.01 | -0.5% | $1.85 | $1.925 | $1.83 | 89,800 | |
| $1.84 | -0.01 | -0.5% | $1.81 | $1.89 | $1.81 | 17,800 | |
| $1.85 | -0.02 | -1.1% | $1.87 | $1.87 | $1.805 | 8,500 | |
| $1.87 | +0.02 | +1.1% | $1.83 | $1.88 | $1.80 | 22,500 | |
| $1.85 | -0.02 | -1.1% | $1.90 | $1.90 | $1.81 | 14,100 | |
| $1.87 | -0.06 | -3.1% | $1.92 | $1.92 | $1.85 | 24,200 | |
| $1.93 | +0.02 | +1.0% | $1.93 | $1.95 | $1.806 | 25,800 | |
| $1.91 | -0.015 | -0.8% | $1.89 | $2.00 | $1.86 | 26,297 | |
| $1.925 | -0.105 | -5.2% | $2.03 | $2.17 | $1.88 | 51,705 | |
| $2.03 | -0.18 | -8.1% | $2.19 | $2.19 | $1.96 | 36,900 | |
| $2.21 | +0.22 | +11.1% | $1.99 | $2.28 | $1.92 | 57,000 |
Splits
1 split · NASDAQ:CDIO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation |
- Ticker
- NASDAQ:CDIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call
Latest deck · Aug 20, 2026
Investor Presentation (August 2026)
Investor deck · 24 slides
Latest news
Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call
Nov 17, 2026
Closed $1.71 (-4.5%) on Nov 17, 2026
Cardio Diagnostics’ Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care
Nov 12, 2026
Closed $1.87 (-2.6%) on Nov 12, 2026
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Aug 18, 2026
Closed $1.91 (-4.0%) on Aug 18, 2026
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
Aug 5, 2026
Closed $1.75 (+0.6%) on Aug 5, 2026
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
Jun 24, 2026
Closed $2.03 (-7.7%) on Jun 24, 2026
Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network
Jun 24, 2026
Closed $2.03 (-7.7%) on Jun 24, 2026
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI
Jun 23, 2026
Closed $2.20 (+11.7%) on Jun 23, 2026
Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine
Jun 18, 2026
Closed $1.98 (0.0%) on Jun 18, 2026
Cardio Diagnostics (NASDAQ: CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection
Jun 15, 2026
Closed $1.97 (+0.5%) on Jun 15, 2026
Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences
May 27, 2026
Closed $1.75 (-1.1%) on May 27, 2026
Cardio Diagnostics Holdings Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 20 in the last 12 months · 108 in all · newest Nov 17, 2026 · oldest 2022
- Decks
- 7 decks · latest Aug 20, 2026
Where Cardio Diagnostics Holdings Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CDIO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CDIO | BOATS | United States | USD |
Valuation
EV/sales 312× against a median of 0.6×: the highest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $4.74M USD
- P/E
- Loss
- EV/sales
- 312×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.8×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 2.07
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cardio Diagnostics Holdings Inc. · NASDAQ:CDIO | US$4.74M | US$4.74M | n/a | 312× | n/a | 0.8× | n/a | 0.0× | 2.07 |
| GENinCode PLC · LSE:GENI | US$5.42M | US$2.86M | n/a | 0.7× | n/a | 2.0× | −185.5% | 0.1× | n/a |
| Nanologica AB · OMXSTO:NICA | US$5.29M | US$8.67M | 2.9× | 1.6× | n/a | 0.3× | 34.9% | 0.3× | n/a |
| VivoSim Labs, Inc. · NASDAQ:VIVS | US$5.29M | −US$2.76M | n/a | −20.5× | n/a | 0.7× | n/a | 0.1× | 1.91 |
| Biomerica, Inc. · NASDAQ:BMRA | US$4.97M | US$2.23M | n/a | 0.5× | n/a | 1.4× | −115.5% | 0.0× | 0.71 |
| VolitionRx Limited · AMEX:VNRX | US$4.87M | US$9.19M | n/a | 2.7× | n/a | n/a | −698.5% | n/a | 1.52 |
| Boule Diagnostics AB · OMXSTO:BOUL | US$4.84M | US$24.70M | n/a | 0.6× | n/a | 0.3× | −4.0% | 1.3× | n/a |
| BioInfra Co.,Ltd. · KRX:199730 | US$4.75M | −US$509,202 | n/a | −0.0× | n/a | 0.5× | −32.3% | 0.0× | n/a |
| Niki BioSolutions, Inc. · NASDAQ:NIKI | US$4.61M | US$4.60M | n/a | n/a | n/a | 0.2× | n/a | 0.1× | 1.46 |
| Cambridge Nutritional Sciences PLC · LSE:CNSL | US$4.51M | US$1.23M | n/a | 0.1× | n/a | 0.6× | −83.5% | 0.0× | n/a |
| Proteome Sciences plc · LSE:PRM | US$4.45M | US$23.87M | n/a | 4.9× | n/a | n/a | −81.5% | n/a | n/a |
| Median of the others | US$4.86M | US$3.73M | 2.9× | 0.6× | 0.6× | −82.5% | 0.1× | 1.49 |
Team and board
Officers
| Officer | Role |
|---|---|
| Meesha Dogan | Chief Executive Officer and Co-Founder |
| Elisa Luqman | Chief Financial Officer |
| Rob Philibert | Chief Medical Officer |
| Tim Dogan | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Warren Hosseinion | Non-Executive Chairman of the Board |
| James Intrater | Director |
| Meesha Dogan | Chief Executive Officer and Co-Founder |
| Paul F. Burton | Board Member |
| Peter K. Fung | Independent Director |
| Rob Philibert | Chief Medical Officer |
| Wendy J. Betts | Independent Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 6, 2026 | +8.7% |
| Q2 2026 | Aug 7, 2026 | +3.0% |
| Q1 2026 | Jun 3, 2026 | −10.2% |
| Q4 2025 | Feb 25, 2026 | +57.7% |
| Q3 2025 | Nov 12, 2025 | −10.8% |
| Q2 2025 | Aug 14, 2025 | −5.0% |
| Q1 2025 | May 15, 2025 · After close | −4.0% |
| Q4 2024 | Mar 20, 2025 | −2.8% |
| Q3 2024 | Nov 13, 2024 · After close | −14.0% |
| Q2 2024 | Aug 12, 2024 · After close | −5.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 15, 2024 · After close | −0.9% |
| Q4 2023 | Feb 28, 2024 | −3.0% |
| Q3 2023 | Nov 13, 2023 · After close | −5.4% |
| Q2 2023 | Aug 14, 2023 · After close | +1.8% |
| Q1 2023 | May 15, 2023 · After close | −15.9% |
| Q4 2022 | Mar 31, 2023 | −6.3% |
| Q3 2022 | Nov 7, 2022 · After close | −2.7% |
| Q2 2022 | Aug 10, 2022 · After close | 0.0% |
| Q1 2022 | May 12, 2022 · After close | 0.0% |
| Quarter to Dec 31, 2021 | Mar 31, 2022 · After close | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 24 slides | Aug 20, 2026 |
| Investor Presentation (February 2026) | Investor deck | 26 slides | Feb 19, 2026 |
| Investor Presentation (February 2025) | Investor deck | 41 slides | Feb 21, 2025 |
| Investor Presentation (April 2024) | Investor deck | 42 slides | Apr 2, 2024 |
| Conference Presentation (September 2023) | Conference | 40 slides | Sep 11, 2023 |
| Corporate Update (May 2023) | Corporate update | 40 slides | May 16, 2023 |
| Mana Capital Acquisition — SPAC Merger (August 2022) | SPAC merger | 29 slides | Aug 26, 2022 |
IPO
Went public as Mana Capital Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Nov 22, 2021.
- Price
- US$10.00 a unit
- Units offered
- 6,200,000 units
- Offering size
- US$62 million
- Underwriters' option
- Up to 930,000 more units
- Listing
- MAAQU on the Nasdaq Global Market
- Underwriters
- LADENBURG THALMANN, I-Bankers Securities, Inc. · In the order on the cover
- Units delivered
- On or about Nov 26, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 20, 2021 |
| Filed publicly | Oct 19, 2021 |
| Amended twice | Newest Nov 17, 2021 |
| Shares registered with an exchange | Nov 22, 2021 |
| Declared effective by the SEC | Nov 22, 2021 |
| Final prospectus, with the price | Nov 24, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Nov 24, 2021 |
| EFFECT · Notice that a registration is effective | Nov 22, 2021 |
| CERT · Exchange's certificate of listing | Nov 22, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 22, 2021 |
| S-1/A · Registration statement, amended | Nov 17, 2021 |
| S-1/A · Registration statement, amended | Nov 10, 2021 |
| S-1 · Registration statement | Oct 19, 2021 |
| DRS · Draft registration statement | Jul 20, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Nov 24, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.8K | 34.9K | 17.1K | 950 | 901 |
| Research and development | 641.2K | 228.0K | 145.2K | 40.4K | 31.5K |
| Operating income | -6.48M | -8.37M | -7.24M | -4.55M | -620.4K |
| Depreciation and amortization | 65.2K | 19.7K | 19.2K | 16.0K | 16.0K |
| EBITDA | -6.42M | -8.35M | -7.22M | -4.53M | -604.4K |
| Interest expense | 14.8K | 18.6K | 6.74M | ||
| Income before tax | -6.50M | -8.38M | -8.38M | -4.66M | -620.4K |
| Income tax | 0 | 0 | |||
| Net income | -6.50M | -8.38M | -8.38M | -4.66M | -620.4K |
| Earnings per share, basic | -3.71 | -9.35 | -0.66 | -1.51 | -0.53 |
| Earnings per share, diluted | -3.71 | -9.35 | -0.66 | -1.51 | -0.53 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.13K | 18.6K | 4.96K | 0 | 901 |
| Current assets | 5.92M | 8.79M | 2.77M | 5.89M | 803.5K |
| Property, plant and equipment | 700.1K | 672.9K | 571.9K | 0 | |
| Total assets | 7.77M | 10.6M | 4.46M | 6.25M | 1.10M |
| Current liabilities | 604.8K | 631.7K | 841.1K | 1.95M | 124.4K |
| Total liabilities | 793.1K | 1.06M | 1.50M | 1.95M | 33.9K |
| Shareholders' equity | 6.97M | 9.56M | 2.96M | 4.30M | 1.07M |
| Shares outstanding | 1.83M | 1.53M | 20.5M | 9.51M | 1.23M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -5.73M | -4.99M | -5.67M | -5.09M | -585.3K |
| Capital spending | -187.3K | -214.8K | -575.7K | ||
| Free cash flow | -5.91M | -5.21M | -6.25M | ||
| Cash from investing | -419.3K | -404.2K | -794.3K | -368.0K | -364.0K |
| Cash from financing | 3.43M | 11.9M | 3.63M | 9.06M | 1.23M |
| Change in cash | -2.72M | 6.54M | -2.83M | 3.60M | 275.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 6, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 18, 2026 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Sep 8, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 20, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 7, 2026 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Aug 7, 2026 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEF 14A · Proxy statement | Aug 5, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Jul 23, 2026 | Annual report | SEC |
| PRE 14A · Preliminary proxy statement | Jul 13, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 10-K · Annual report | Mar 13, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 19, 2026 | Current report | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 15, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 424B3 · Prospectus | Sep 23, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 22, 2025 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Sep 16, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Sep 11, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 10, 2025 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Sep 5, 2025 | Offer document | SEC |
| DEFA14A · Additional proxy material | Sep 4, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 4, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Aug 27, 2025 | Annual report | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Aug 13, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 8-K · Current report | May 28, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | May 21, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 16, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | May 7, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 24, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Apr 8, 2025 | Offer document | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 424B3 · Prospectus | Mar 25, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Mar 25, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 20, 2025 | Annual report | SEC |
| 3 · Initial statement of ownership | Mar 13, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 21, 2025 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Feb 18, 2025 | Other filings | SEC |
| 424B5 · Prospectus | Feb 14, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 13, 2025 | Other filings | SEC |
| S-3 · Registration statement | Feb 7, 2025 | Offer document | SEC |
| 3 · Initial statement of ownership | Feb 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 4, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Dec 4, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Dec 3, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 2, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 26, 2024 | Other filings | SEC |
| S-1 · Registration statement | Nov 22, 2024 | Offer document | SEC |
| 8-K · Current report | Nov 18, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 9, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 8, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 7, 2024 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Oct 4, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 4, 2024 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Sep 25, 2024 | Annual report | SEC |
| PRE 14A · Preliminary proxy statement | Sep 23, 2024 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Sep 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 9, 2024 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Sep 6, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Aug 30, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 12, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 7, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | May 8, 2024 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Apr 26, 2024 | Offer document | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 8-K · Current report | Apr 2, 2024 | Current report | SEC |
| 424B3 · Prospectus | Apr 1, 2024 | Offer document | SEC |
| 10-K · Annual report | Apr 1, 2024 | Annual report | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| D | Feb 5, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 2, 2024 | Financing | SEC |
| SC 13G · Big-stake notice | Feb 2, 2024 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Feb 2, 2024 | Other filings | SEC |
| 424B5 · Prospectus | Feb 1, 2024 | Offer document | SEC |
| 8-K · Current report | Feb 1, 2024 | Material contract | SEC |
| CORRESP · Letter to the SEC | Jan 30, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 30, 2024 | Other filings | SEC |
| DEL AM | Jan 29, 2024 | Other filings | SEC |
| S-3 · Registration statement | Jan 26, 2024 | Offer document | SEC |
| 8-K · Current report | Jan 4, 2024 | Current report | SEC |
| 3 · Initial statement of ownership | Jan 4, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 19, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Dec 6, 2023 | Current report | SEC |
| 8-K · Current report | Nov 22, 2023 | Current report | SEC |
| DEFA14A · Additional proxy material | Nov 22, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 3, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Nov 3, 2023 | Insider trade | SEC |
| DEF 14A · Proxy statement | Oct 27, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 12, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Oct 4, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 4, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 4, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2023 | Current report | SEC |
| 8-K/A · Current report, amended | Sep 14, 2023 | Material contract | SEC |
| 8-K · Current report | Sep 11, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 28, 2023 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 28, 2023 | Big-stake notice | SEC |
| 4/A · Change in ownership, amended | Jun 27, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 22, 2023 | Material contract | SEC |
| 4 · Change in ownership | Jun 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2023 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jun 5, 2023 | Material contract | SEC |
| 8-K · Current report | May 30, 2023 | Meeting outcome | SEC |
| 8-K · Current report | May 16, 2023 | Current report | SEC |
| 424B3 · Prospectus | May 15, 2023 | Offer document | SEC |
| 424B3 · Prospectus | May 15, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| DEF 14A · Proxy statement | May 3, 2023 | Meeting notice | SEC |
| 424B3 · Prospectus | May 1, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 1, 2023 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Apr 24, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Apr 12, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Apr 11, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Apr 10, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 10, 2023 | Other filings | SEC |
This page holds 200 of 296 filings. Open Filings
Cap table
Built by 6ix from Cardio Diagnostics Holdings Inc.’s releases · as of Nov 6, 2026
- Common shares
- 2,959,469
- Fully diluted
- 2,959,469
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 2,959,469 | Nov 6, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 6, 2026 | 2,959,469 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Warren Hosseinion Other companies: Veraxa Biotech AG (Director · Since at least Jun 9, 2026); General Purpose Acquisition Corp. (Director · Since at least Dec 2, 2025); Nutex Health Inc. (President, Director · Since at least Mar 1, 2025) | Non-Executive Chairman of the Board · Since at least Nov 5, 2026 |
| Elisa Luqman Other companies: Nutex Health Inc. (Chief Legal Officer - SEC · Since at least Jan 28, 2021) | Chief Financial Officer · Since at least Oct 25, 2022 |
| Russell Jukes Other companies: DXC Technology Company (Chief Digital Information Officer · Since at least Feb 10, 2026) | Chief Digital Information Officer · Dec 8, 2025 – Nov 5, 2026 · Past |
| James Intrater | Director · Since at least Oct 25, 2022 |
| Meesha Dogan | Chief Executive Officer and Co-Founder · Since at least Aug 18, 2026 |
| Meeshanthini Dogan | Chief Executive Officer, Director · Oct 25, 2022 – Sep 6, 2024 · Past |
| Oded Levy | Director · Oct 25, 2022 – Sep 30, 2024 · Past |
| Paul Burton | Director · Since at least Dec 18, 2023 |
| Peter K. Fung | Independent Director · Since at least Nov 5, 2026 |
| Rob Philibert | Chief Medical Officer · Since at least Mar 26, 2025 |
All 13 people
| Person | Seat |
|---|---|
| Tim Dogan | Chief Technology Officer · Since at least Nov 6, 2025 |
| Timur Dogan | Chief Technology Officer · Oct 25, 2022 – Sep 6, 2024 · Past |
| Wendy J. Betts | Director · Since at least Dec 31, 2024 |
Log in to ask 6ix AI your own questions about Cardio Diagnostics Holdings Inc.